Kavita V Nair

Summary

Affiliation: University of Colorado Denver
Country: USA

Publications

  1. ncbi Work absences and expenditures for employees with autoimmune inflammatory diseases
    Kavita V Nair
    School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    J Occup Environ Med 54:1268-74. 2012
  2. ncbi Burden of illness for an employed population with chronic obstructive pulmonary disease
    Kavita Nair
    School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
    Popul Health Manag 15:267-75. 2012
  3. ncbi Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan
    Kavita V Nair
    School of Pharmacy, University of Colorado, Aurora, Colorado, USA
    J Health Care Finance 38:38-53. 2011
  4. ncbi Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    R Brett McQueen
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Cost Eff Resour Alloc 9:13. 2011
  5. ncbi Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis
    Kavita V Nair
    School of Pharmacy, C238 L15, University of Colorado Denver, Academic Office 1, 12631 E 17th Avenue, Room L15 1406, PO Box 6511, Aurora, CO 80045, USA
    Expert Rev Neurother 11:787-98. 2011
  6. ncbi Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers
    Kavita V Nair
    School of Pharmacy, University of Colorado at Denver, Aurora, Colo 80045, USA
    J Occup Environ Med 51:594-603. 2009
  7. ncbi Prescription co-pay reduction program for diabetic employees
    Kavita V Nair
    School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
    Popul Health Manag 13:235-45. 2010
  8. ncbi Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease
    Kavita V Nair
    University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Ave, Box C 238, Denver, CO 80262, USA
    J Manag Care Pharm 9:123-33. 2003
  9. ncbi A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
    Robert J Valuck
    University of Colorado Health Sciences Center, School of Pharmacy, Denver, Colorado 80262, USA
    Clin Ther 25:2936-57. 2003
  10. ncbi Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations
    Kavita V Nair
    University of Colorado Denver, Aurora, CO, USA
    Curr Med Res Opin 25:303-14. 2009

Collaborators

Detail Information

Publications21

  1. ncbi Work absences and expenditures for employees with autoimmune inflammatory diseases
    Kavita V Nair
    School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
    J Occup Environ Med 54:1268-74. 2012
    ..Economic burden was compared for employees with autoimmune inflammatory diseases (AutoIDs) who received anti-tumor necrosis factor (TNF) α agents, those who did not, and those with no AutoID...
  2. ncbi Burden of illness for an employed population with chronic obstructive pulmonary disease
    Kavita Nair
    School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
    Popul Health Manag 15:267-75. 2012
    ..By understanding these costs, employers may evaluate disease management programs and treatment to improve outcomes for employees with COPD. Improved treatment options may reduce the direct and indirect costs of COPD...
  3. ncbi Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan
    Kavita V Nair
    School of Pharmacy, University of Colorado, Aurora, Colorado, USA
    J Health Care Finance 38:38-53. 2011
    ..To examine the impact of the coverage gap on pharmacy use, expenditures, and out-of-pocket costs for Medicare managed care beneficiaries before and after reaching the gap...
  4. ncbi Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    R Brett McQueen
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Cost Eff Resour Alloc 9:13. 2011
    ..abstract:..
  5. ncbi Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis
    Kavita V Nair
    School of Pharmacy, C238 L15, University of Colorado Denver, Academic Office 1, 12631 E 17th Avenue, Room L15 1406, PO Box 6511, Aurora, CO 80045, USA
    Expert Rev Neurother 11:787-98. 2011
    ..7%) and liver function tests (60.5%). Relative to non-DMT users (n = 25,534), DMT users were more likely to receive an MRI, neuropsychological testing, chemistry panels, complete blood cell counts and liver function tests...
  6. ncbi Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers
    Kavita V Nair
    School of Pharmacy, University of Colorado at Denver, Aurora, Colo 80045, USA
    J Occup Environ Med 51:594-603. 2009
    ..The impact of consumer-driven health plans (CDHPs) on utilization and expenditures for members with chronic diseases...
  7. ncbi Prescription co-pay reduction program for diabetic employees
    Kavita V Nair
    School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
    Popul Health Manag 13:235-45. 2010
    ..In addition to financial strategies, additional strategies to reinforce medication adherence are needed to gain and sustain more meaningful increases in prescription utilization...
  8. ncbi Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease
    Kavita V Nair
    University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Ave, Box C 238, Denver, CO 80262, USA
    J Manag Care Pharm 9:123-33. 2003
    ..To evaluate the impact of 3-tier (copayment) pharmacy benefit structures on medication utilization behavior...
  9. ncbi A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization
    Robert J Valuck
    University of Colorado Health Sciences Center, School of Pharmacy, Denver, Colorado 80262, USA
    Clin Ther 25:2936-57. 2003
    ..Few studies have examined the effectiveness of statins in a managed care setting...
  10. ncbi Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations
    Kavita V Nair
    University of Colorado Denver, Aurora, CO, USA
    Curr Med Res Opin 25:303-14. 2009
    ..To evaluate how changes in infliximab dose influence resource utilization and expenditures for patients with rheumatoid arthritis (RA)...
  11. ncbi Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks
    Joseph J Saseen
    University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Mail Stop C238, 12850 E Montview Blvd, V20 2126, Aurora, CO 80045, USA
    Rheumatology (Oxford) 51:2004-12. 2012
    ..03). Conclusion. Patients with frequent gouty arthritis are likely to have absolute and/or relative contraindications to gout medications and higher gout-related treatment costs...
  12. ncbi Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions
    Julie C Alford
    Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Aurora, CO 80045, USA
    Pharmacotherapy 32:623-30. 2012
    ..To describe the prevalence of prescribing against-label statin-fibrate combination therapy...
  13. ncbi An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
    Jacqueline A Pesa
    Janssen Scientific Affairs, LLC, Louisville, CO, USA
    Patient Prefer Adherence 6:63-72. 2012
    ....
  14. ncbi Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
    Robert Lee Page
    School of Pharmacy, Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO
    Drug Healthc Patient Saf 4:67-74. 2012
    ..No data exist regarding the effect of the Medicare Part D coverage gap on medical costs and outcomes in Medicare beneficiaries who discontinue their clopidogrel upon entering the coverage gap...
  15. ncbi Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey
    Kavita V Nair
    School of Pharmacy, University of Colorado, Aurora, CO, USA
    Patient Prefer Adherence 5:195-206. 2011
    ..Using customized telephonic outreach, we examined specific patient-reported barriers influencing hypertensive patients' nonadherence to medication in order to identify targeted interventions...
  16. ncbi Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents
    Michele R Hanselin
    Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 E Montview Blvd, V20 2126, Aurora, CO 80045, USA
    Hypertension 58:1008-13. 2011
    ..Moreover, minimally efficacious combinations, such as an angiotensin-converting enzyme inhibitor with an angiotensin receptor blocker, were prescribed at higher rates than evidence-based and recommended agents...
  17. ncbi Consumer responses to a pharmacy benefit report card
    Kavita V Nair
    School of Pharmacy, University of Colorado Health Sciences Center, USA
    J Health Care Finance 31:55-72. 2004
    ..The pharmacy benefit report card could be an useful tool for specific populations such as those with an increased need for medication...
  18. ncbi Quality assessment of dyslipidemia in managed care: current best evidence should be used to benchmark quality
    Kavita V Nair
    School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262 0001, USA
    Ann Pharmacother 40:124-7. 2006
    ..We propose a broad framework that provides health plans with guidance on developing a new quality measure for dyslipidemia that focuses on pharmacotherapy...
  19. ncbi Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States
    Julia F Slejko
    Department of Clinical Pharmacy, Center for Pharmaceutical Outcomes Research, University of Colorado Aschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045, USA
    Res Social Adm Pharm 9:108-13. 2013
    ..Evidence is missing on showcasing current practices of degree programs specific to the field of pharmaceutical outcomes research...
  20. ncbi Do consumers' attitudes predict prescription purchasing behavior?
    Kavita V Nair
    School of Pharmacy, University of Colorado Health Sciences Center, Denver, USA
    Manag Care Interface 16:22-7, 55. 2003
    ..The findings appear to support the concept of three-tier plans, and increasing copayments seems to facilitate greater adherence to health plan formularies...
  21. ncbi Utilization characteristics of spinal interventions
    Zach I Abbott
    Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, 12631 East 17th Ave, Room 2507, Mail Stop F493, Aurora, CO 80045, USA
    Spine J 12:35-43. 2012
    ..Although Medicare utilization has been well characterized, the utilization patterns for privately insured individuals are not clearly known...